Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novozymes A/S Starts Cooperation with Syngenta AG-Ritzau


Friday, 26 Oct 2012 01:10am EDT 

Ritzau reported that Novozymes A/S and Syngenta AG have started a cooperation on Taegro, a fermented biological mycotoxins based on the bacterium Bacillus subtilis. The two companies will jointly market and distribute the new product, which is based on Novozymes technology. Taegro is already approved in the U.S. market, but will now be extended to the rest of the world. 

Company Quote

70.98
-0.6 -0.84%
22 Aug 2014